Importance of innovation
Mid-summer for The Journal is marked by the Pharmaceutical Care Awards, and the finalists for 2006 were recognised
at a conference and dinner at the end of last week (pp10–14). This year, we departed from the norm and did not select winners and runners-up. Instead we decided that all seven finalists justified receiving the same prize and the right to call themselves a winner of a Pharmaceutical Care Award.
As ever, there were strong entries from Scotland, and it was pleasing
to note that supplementary prescribing featured in two projects. Interestingly,
and possibly explained in the recruitment
feature in The Journal last
week (30 June, p771), the expected clutch of finalists from primary care
pharmacists in England was not evident. With so much uncertainty in the
sector, following the merger and realignment of many primary care trusts,
those pharmacists clearly had other matters on their minds. We look forward
to receiving their entries next year.
We are grateful to our two sponsors: GlaxoSmithKline, which has supported
the awards for 15 years, and the Company Chemists’ Association,
which we welcomed for a second year. Richard Heath, director of commercial
operations at GSK, made the observation that, although the general quality
of the care award entries has been excellent over the years, the environment
in which pharmacy operates now would have been unrecognisable when the
awards were launched 15 years ago.
Digby Emson, chairman of the CCA,
echoed this point by looking to the future and the further development
of pharmacy: “Whether it’s new ways of coronary heart disease
screening, developing a patient group direction for obesity or new diabetes
screening, innovation is very important to us.”
We can only agree and look forward to next year’s examples of innovation
in pharmaceutical care. Back to Top |
New crew at the Department of Health
Harold Wilson said a week is a long time in politics — something that Lord Hunt must be pondering now that he is no longer the Government minister with responsibility for pharmacy. Alan Johnson, the new Secretary of State for Health, and his crew are now at the helm of the good ship Department of Health and it will be interesting to see who is given responsibility for pharmacy and in which direction the profession will be steered.
Uppermost in people’s minds in Lambeth is whether the new minister will
take a different view to the reconstitution of the Royal Pharmaceutical Society
and whether the priorities in the DoH will change. Let us hope that whoever takes
ministerial responsibility for pharmacy will appreciate that the profession needs
to have some idea of the compass points, its ultimate destination and the estimated
time of arrival — and that pharmacy is not left bobbing about in uncharted
and increasingly turbulent seas.
Back to Top
|